Africa’s CDC explains how a vaccine waiver would help its lagging rollout

Africa’s CDC explains how a vaccine waiver would help its lagging rollout
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

In a contentious reversal of its previous position, the US on May 6 announced its support for a suspension of intellectual property rights on Covid-19 vaccines. The African Union’s public health agency applauded the move, saying the waiver would offer the continent a “unique” opportunity to advance its vaccine manufacturing. The US’ decision isn’t enough on its own: The IP proposal requires unanimous support from the World Trade Organization’s member countries, and many (including the European Union) remain opposed.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting